These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 24864079)

  • 21. An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.
    Mohammadnia N; Opstal TSJ; El Messaoudi S; Bax WA; Cornel JH
    Clin Ther; 2023 Nov; 45(11):1055-1059. PubMed ID: 37716836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.
    Thacker SG; Zarzour A; Chen Y; Alcicek MS; Freeman LA; Sviridov DO; Demosky SJ; Remaley AT
    Immunology; 2016 Nov; 149(3):306-319. PubMed ID: 27329564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
    Ridker PM
    Circulation; 2020 Mar; 141(10):787-789. PubMed ID: 32150469
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits.
    Spartalis M; Siasos G; Mastrogeorgiou M; Spartalis E; Kaminiotis VV; Mylonas KS; Kapelouzou A; Kontogiannis C; Doulamis IP; Toutouzas K; Nikiteas N; Iliopoulos DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7765-7776. PubMed ID: 34982438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease.
    Ridker PM; Rane M
    Circ Res; 2021 May; 128(11):1728-1746. PubMed ID: 33998272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
    Klingenberg R; Hansson GK
    Eur Heart J; 2009 Dec; 30(23):2838-44. PubMed ID: 19880848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
    Biondi-Zoccai G; Garmendia CM; Abbate A; Giordano A; Frati G; Sciarretta S; Antonazzo B; Versaci F
    Curr Atheroscler Rep; 2020 Jan; 22(1):4. PubMed ID: 31932973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerosis: perspectives of anti-inflammatory therapy.
    Nasonov EL; Popkova TV
    Ter Arkh; 2018 May; 90(5):4-12. PubMed ID: 30701884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Inflammatory Therapy in Coronary Artery Disease: Where Do We Stand?
    Rakocevic J; Dobric M; Borovic ML; Milutinovic K; Milenkovic S; Tomasevic M
    Rev Cardiovasc Med; 2023 Jan; 24(1):10. PubMed ID: 39076864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.
    Ridker PM; MacFadyen JG; Thuren T; Libby P
    Eur Heart J; 2020 Jun; 41(23):2153-2163. PubMed ID: 31504417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-atherosclerosis of oligomeric proanthocyanidins from Rhodiola rosea on rat model via hypolipemic, antioxidant, anti-inflammatory activities together with regulation of endothelial function.
    Zhou Q; Han X; Li R; Zhao W; Bai B; Yan C; Dong X
    Phytomedicine; 2018 Dec; 51():171-180. PubMed ID: 30466614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.
    Cronstein BN; Sunkureddi P
    J Clin Rheumatol; 2013 Jan; 19(1):19-29. PubMed ID: 23319019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
    BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
    Ridker PM; MacFadyen JG; Thuren T; Everett BM; Libby P; Glynn RJ;
    Lancet; 2017 Oct; 390(10105):1833-1842. PubMed ID: 28855077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.
    Ait-Oufella H; Libby P; Tedgui A
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1510-1519. PubMed ID: 31294625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol-embolization syndrome: current perspectives.
    Ozkok A
    Vasc Health Risk Manag; 2019; 15():209-220. PubMed ID: 31371977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.